Cogstate Limited

Research Cogstate Limited (CGS.AX) on Bullrun: market cap AUD 628.26M, P/E 36.5, dividend yield 1.1%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is AUD 628.26M; P/E is 36.5; dividend yield is 1.1%.

Peer valuation comparison

Latest P/E is 36.5x versus a Healthcare sector median of 24.73x (47.6% above).

Latest dividend yield is 1.1% versus a Healthcare sector median of 1.81% (39.2% below).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2026USD 58.37MUSD 11.90MUSD 2.20M58.0%n/aUSD 34.78MUSD 359.18KUSD 58.27M
FY2025USD 50.81MUSD 10.14MUSD 8.40M60.4%0.06USD 35.56MUSD 469.92KUSD 47.90M
FY2024USD 43.43MUSD 5.45MUSD 3.90M56.9%0.03USD 30.12MUSD 672.72KUSD 40.92M
FY2023USD 40.45MUSD 3.57M-USD 1.56M53.4%0.02USD 28.68MUSD 378.89KUSD 37.69M
FY2022n/an/an/an/a0.04n/an/an/a

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-17AUD 628.26M36.51.1%0.04

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0.04 AUD, yield 1.1%.

YearDividends/share
FY20260.04 USD
FY20250.02 USD

About Cogstate Limited

Cogstate Limited, a neuroscience solutions company, engages in the creation, validation, and commercialization of digital brain health assessments worldwide.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Cogstate Limited's market cap?

Cogstate Limited's market capitalization is AUD 628.26M.

What is Cogstate Limited's P/E ratio?

Cogstate Limited's price-to-earnings (P/E) ratio is 36.5.

Does Cogstate Limited pay a dividend?

Cogstate Limited has a dividend yield of 1.1%.

What does Cogstate Limited do?

Cogstate Limited, a neuroscience solutions company, engages in the creation, validation, and commercialization of digital brain health assessments worldwide.